Analysts Viewpoint
An Analysis of Revolution Medicines Inc (RVMD)’s Potential Price Growth
Revolution Medicines Inc’s recent filing unveils that its Director MARK A GOLDSMITH acquired Company’s shares for reported $1.49 million on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.